Post Marketing Observational/Non-Interventional Study Of Retreatment Of Chronic Hepatitis C With Peginterferon Alpha And Ribavirin.
Phase of Trial: Phase IV
Latest Information Update: 19 Nov 2012
At a glance
- Drugs Peginterferon alfa (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- Acronyms POMOSCH
- Sponsors Schering-Plough
- 10 Jan 2012 Actual patient number (790) added as reported by ClinicalTrials.gov.
- 07 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jan 2011 Planned end date changed from Mar 2011 to Sep 2011 as reported by ClinicalTrials.gov.